[go: up one dir, main page]

BG101401A - Състави за орално приложение с удължено освобождаване на цисаприд - Google Patents

Състави за орално приложение с удължено освобождаване на цисаприд

Info

Publication number
BG101401A
BG101401A BG101401A BG10140197A BG101401A BG 101401 A BG101401 A BG 101401A BG 101401 A BG101401 A BG 101401A BG 10140197 A BG10140197 A BG 10140197A BG 101401 A BG101401 A BG 101401A
Authority
BG
Bulgaria
Prior art keywords
cisaprid
oral compositions
overall release
release
overall
Prior art date
Application number
BG101401A
Other languages
English (en)
Other versions
BG63244B1 (bg
Inventor
Eugene JANS
Paul Gilis
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of BG101401A publication Critical patent/BG101401A/bg
Publication of BG63244B1 publication Critical patent/BG63244B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cereal-Derived Products (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Изобретението се отнася до форми, съдържащи цисаприд-(L)-тартарат, по-специално за орално приложение, и до използването им в медицината при лечение на смущения в стомашно-чревната кинетика.
BG101401A 1994-11-02 1997-04-10 Състави за орално приложение с удължено освобождаване на цисаприд BG63244B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203184 1994-11-02
PCT/EP1995/004198 WO1996014070A1 (en) 1994-11-02 1995-10-25 Cisapride extended release oral compositions

Publications (2)

Publication Number Publication Date
BG101401A true BG101401A (bg) 1997-12-30
BG63244B1 BG63244B1 (bg) 2001-07-31

Family

ID=8217338

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101401A BG63244B1 (bg) 1994-11-02 1997-04-10 Състави за орално приложение с удължено освобождаване на цисаприд

Country Status (29)

Country Link
US (2) US6153623A (bg)
EP (1) EP0789572A1 (bg)
JP (1) JP3182423B2 (bg)
KR (1) KR100255521B1 (bg)
AP (1) AP658A (bg)
AR (1) AR001765A1 (bg)
AU (1) AU704284B2 (bg)
BG (1) BG63244B1 (bg)
BR (1) BR9509565A (bg)
CA (1) CA2203663C (bg)
CZ (1) CZ287844B6 (bg)
EE (1) EE03510B1 (bg)
FI (1) FI971856L (bg)
HR (1) HRP950539A2 (bg)
HU (1) HUT77887A (bg)
IL (1) IL115843A0 (bg)
MY (1) MY113092A (bg)
NO (1) NO312538B1 (bg)
NZ (1) NZ295166A (bg)
OA (1) OA10419A (bg)
PL (1) PL181470B1 (bg)
RO (1) RO116042B1 (bg)
RU (1) RU2143890C1 (bg)
SK (1) SK54297A3 (bg)
TR (1) TR199501351A2 (bg)
TW (1) TW466114B (bg)
UA (1) UA50721C2 (bg)
WO (1) WO1996014070A1 (bg)
ZA (1) ZA959221B (bg)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
AU1096697A (en) * 1995-12-01 1997-06-27 Janssen Pharmaceutica N.V. Cisapride sustained release
ATE220543T1 (de) * 1996-04-23 2002-08-15 Janssen Pharmaceutica Nv Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid
JP2001507359A (ja) * 1997-01-03 2001-06-05 エラン コーポレーション ピーエルシー 徐放性シサプリドミニ錠剤製剤
JP2002504107A (ja) * 1997-06-11 2002-02-05 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ （＋）−または（−）−シサプリドの即時放出性ｐＨ非依存的固形投薬剤形
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
CO5140079A1 (es) * 1998-10-14 2002-03-22 Novartis Ag Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
WO2000059477A1 (en) 1999-03-31 2000-10-12 Janssen Pharmaceutica N.V. Pregelatinized starch in a controlled release formulation
EP1060743A1 (en) * 1999-06-17 2000-12-20 Development Center For Biotechnology Oral cisapride dosage forms with an extended duration
BR0014383A (pt) * 1999-09-28 2002-10-22 Panacea Biotec Ltd Composições de liberação controlada compreendendo nimesulida
ATE361060T1 (de) * 2000-09-29 2007-05-15 Solvay Pharm Bv Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
ATE408400T1 (de) * 2002-05-21 2008-10-15 Watson Lab Inc Pharmazeutische zusammensetzung mit verzögerter freisetzung
JP5208729B2 (ja) 2006-04-12 2013-06-12 日本曹達株式会社 徐放性錠剤の製造方法
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
DK3045043T3 (da) 2009-02-26 2020-08-03 Relmada Therapeutics Inc Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
EP0632720B1 (en) * 1992-03-25 1998-11-11 Depomed Systems, Inc. Hydroxyethylcellulose-based sustained-release oral drug dosage froms
EP1145715A3 (en) * 1992-07-07 2004-05-19 Sepracor Inc. Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
CZ287844B6 (en) 2001-02-14
NO971832L (no) 1997-04-21
JP3182423B2 (ja) 2001-07-03
AP658A (en) 1998-08-17
HUT77887A (hu) 1998-09-28
CA2203663A1 (en) 1996-05-17
AU3844795A (en) 1996-05-31
RU2143890C1 (ru) 2000-01-10
WO1996014070A1 (en) 1996-05-17
AP9700969A0 (en) 1997-04-30
AU704284B2 (en) 1999-04-15
JPH09511760A (ja) 1997-11-25
US6274599B1 (en) 2001-08-14
IL115843A0 (en) 1996-01-31
TW466114B (en) 2001-12-01
SK54297A3 (en) 1997-10-08
RO116042B1 (ro) 2000-10-30
MY113092A (en) 2001-11-30
US6153623A (en) 2000-11-28
NO312538B1 (no) 2002-05-27
OA10419A (en) 2001-12-06
BR9509565A (pt) 1997-09-16
NZ295166A (en) 1999-03-29
BG63244B1 (bg) 2001-07-31
EP0789572A1 (en) 1997-08-20
FI971856A7 (fi) 1997-04-30
FI971856A0 (fi) 1997-04-30
KR100255521B1 (ko) 2000-05-01
TR199501351A2 (tr) 1996-06-21
EE03510B1 (et) 2001-10-15
NO971832D0 (no) 1997-04-21
FI971856L (fi) 1997-04-30
CZ124497A3 (en) 1997-08-13
HRP950539A2 (en) 1997-08-31
ZA959221B (en) 1997-04-30
EE9700105A (et) 1997-12-15
UA50721C2 (uk) 2002-11-15
AR001765A1 (es) 1997-12-10
PL319948A1 (en) 1997-09-01
PL181470B1 (pl) 2001-07-31
MX9703249A (es) 1997-07-31
CA2203663C (en) 2002-04-30

Similar Documents

Publication Publication Date Title
TR199501447A2 (tr) Oral bilesimler.
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
TR26855A (tr) Dis-tasina karsi agiz bilesimleri.
TR199501325A2 (tr) Protez dis sabitlestirme terkipleri.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
SE9802729D0 (sv) Novel Compounds
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
DE68901390D1 (de) Orale zusammensetzung gegen zahnstein.
TR199501650A2 (tr) Agiz bilesimleri.
DE69012702D1 (de) Dentalzusammensetzung.
ITRM940002A0 (it) Composizione orale.
TR199501645A2 (tr) Agiz bilesimleri.
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
ID23772A (id) Komposisi-komposisi melalui mulut
BG106316A (bg) Съдържаща амброксол таблетка за смучене
BG100248A (bg) Инхибитори на скваленсинтетаза
HRP20000400B1 (hr) Transmukozni pripravci levosimendana
DE69300492D1 (de) Orale Zusammensetzung.
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
ES2152315T3 (es) Xamoneline tartrato.
HRP20050611A2 (en) Combination medicament
TR199501649A2 (tr) Agiz bilesimleri.
TR199501651A2 (tr) Agiz bilesimleri.
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele